temozolomide has been researched along with gossypol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kögel, D; Lang, V; Ronellenfitsch, MW; Seifert, V; Senft, C; Steinbach, JP; Voss, V | 1 |
| Li, S; Liu, Y; Sun, P; Ying, H | 1 |
| Adamski, V; Adelung, R; Ceynowa, F; Hattermann, K; Held-Feindt, J; Lucius, R; Schmitt, C; Synowitz, M | 1 |
| Jang, H; Jeon, JH; Kang, SG; Kang, SW; Kim, DK; Kim, HY; Kim, SY; Lee, BI; Shim, JK | 1 |
| Adamski, V; Adelung, R; Hattermann, K; Held-Feindt, J; Lucius, R; Rasch, F; Schmitt, C; Synowitz, M | 1 |
| Caylioglu, D; Held-Feindt, J; Hellmold, D; Kubelt, C; Meyer, RJ; Synowitz, M | 1 |
| Adelung, R; Beckinger, S; Daunke, T; Haag, J; Hauck, M; Held-Feindt, J; Hellmold, D; Janssen, O; Kubelt, C; Lucius, R; Schütt, F; Sebens, S; Synowitz, M | 1 |
8 other study(ies) available for temozolomide and gossypol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma.
Topics: Animals; Apoptosis; Autophagy; Caspases; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Enzyme Activation; Glioma; Gossypol; Humans; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction; Temozolomide; Transfection; Tumor Suppressor Proteins | 2010 |
Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Bucladesine; Bystander Effect; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Connexin 43; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Gap Junctions; Gossypol; Humans; Medulloblastoma; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction; Simplexvirus; Temozolomide; Teniposide; Thymidine Kinase | 2012 |
Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; Drug Administration Schedule; Drug Synergism; Glioblastoma; Gossypol; Humans; Hydroxychloroquine; Temozolomide | 2018 |
Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Proliferation; Cell Survival; Combined Modality Therapy; Contraceptive Agents, Male; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glioblastoma; Gossypol; Humans; Male; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Temozolomide; Tumor Cells, Cultured | 2019 |
Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing.
Topics: Analysis of Variance; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Astrocytes; Brain; Coculture Techniques; Glioblastoma; Gossypol; Humans; Microglia; Temozolomide | 2020 |
Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Gossypol; Humans; Neoplastic Stem Cells; Signal Transduction; Stem Cell Niche; Temozolomide; Tumor Microenvironment | 2021 |
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Gossypol; Humans; Neoplasm Recurrence, Local; Temozolomide; TOR Serine-Threonine Kinases | 2023 |